ResearcherFred Hutch Cancer CenterActive in the last 2 years
Ying‐Qi Zhao
Matched on ORCID iD 0000-0002-2851-2257; OpenAlex author ID A5050444279; NIH RePORTER profile ID 11581247. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 14
2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers, 1 grant
Papers 3
- Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. Co-author DOI 10.1053/j.gastro.2025.06.025↗
- Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. Co-author DOI 10.1093/jnci/djaf291↗
- Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detectio… Co-author DOI 10.1016/j.cct.2021.106659↗
Grants 1
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Suresh T. Chari · 3 shared papers, 1 shared grant, 2022–2026 · strength 1.92
- Grant Developing methods for advancing the early detection of pancreatic ductal adenocarcinoma leveraging electronic medical … R01CA289668↗
- Paper Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. DOI 10.1093/jnci/djaf291↗
- Paper Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. DOI 10.1053/j.gastro.2025.06.025↗
- Barbara J. Kenner · 3 shared papers, 2022–2026 · strength 0.66
- Paper Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. DOI 10.1093/jnci/djaf291↗
- Paper Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. DOI 10.1053/j.gastro.2025.06.025↗
- Paper Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyper… DOI 10.1016/j.cct.2021.106659↗
- Anirban Maitra · 3 shared papers, 2022–2026 · strength 0.66
- Paper Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. DOI 10.1093/jnci/djaf291↗
- Paper Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. DOI 10.1053/j.gastro.2025.06.025↗
- Paper Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyper… DOI 10.1016/j.cct.2021.106659↗
- Ziding Feng · 3 shared papers, 2022–2026 · strength 0.66
- Paper Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. DOI 10.1093/jnci/djaf291↗
- Paper Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. DOI 10.1053/j.gastro.2025.06.025↗
- Paper Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyper… DOI 10.1016/j.cct.2021.106659↗
- Bechien U. Wu · 3 shared papers, 2022–2026 · strength 0.66
- Paper Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. DOI 10.1093/jnci/djaf291↗
- Paper Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. DOI 10.1053/j.gastro.2025.06.025↗
- Paper Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyper… DOI 10.1016/j.cct.2021.106659↗
- Lynn McCormick Matrisian · 3 shared papers, 2022–2026 · strength 0.66
- Paper Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. DOI 10.1093/jnci/djaf291↗
- Paper Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. DOI 10.1053/j.gastro.2025.06.025↗
- Paper Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyper… DOI 10.1016/j.cct.2021.106659↗
- William E Fisher · 2 shared papers, 2026 · strength 0.52
- Avinash R. Kambadakone · 2 shared papers, 2022–2026 · strength 0.44
- Jo Ann Rinaudo · 2 shared papers, 2022–2026 · strength 0.36
- Kari G. Rabe · 1 shared paper, 2026 · strength 0.22
- Phil A. Hart · 1 shared paper, 2026 · strength 0.22
- Santhi Swaroop Vege · 1 shared paper, 2026 · strength 0.22
- Sudhir Srivastava · 1 shared paper, 2022 · strength 0.14
- Ying Huang · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.